Across TCGA pan-cancer cohorts, ABCA4 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated ABCA4 data layer compared with 11 for mutation status.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ABCA4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ABCA4 expression acts as an unfavorable survival marker, although some lineages such as LUAD and UCEC show a favorable association.
BLCA, KIRP, and SKCM are the cancer types where ABCA4 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.